Hostname: page-component-848d4c4894-ndmmz Total loading time: 0 Render date: 2024-04-30T13:42:19.636Z Has data issue: false hasContentIssue false

The effect of several doses of oral tocainide HC1 on tinnitus: a dose-finding study

Published online by Cambridge University Press:  27 May 2011

Jan H. Hulshof
Affiliation:
(Leiden, The Netherlands)
Pieter Vermey
Affiliation:
(Leiden, The Netherlands)

Extract

From all methods of the treatment of tinnitus, medical, masking, surgery, electrical stimulation and psychological, we believe a reliable medical treatment would be preferable because it is easy to apply. An immense variety of drugs have been used for the treatment of tinnitus (Vernon, 1977). The most reliable drugs so far on tinnitus are intravenous procaine and lidocaine (Bárány, 1935; Lewy, 1937; Melding et al., 1978; Martin and Colman, 1980; Israel et al., 1982). The fact that these drugs cannot be given orally because of the poor biological availability after oral administration, is a great disadvantage. In view of the important pharmaco-therapeutic role of lidocaine as an anti-arrhythmic drug, considerable research has been devoted to drugs with comparable anti-arrhythmic properties but permitting oral administration. This work produced tocainide (Smith, 1981), which showed a certain degree of effect on tinnitus as well (Emmett and Shea, 1980; Cathcart, 1982). Before starting a randomized double-blind controlled trial to assess the effect on tinnitus of tocainide, we studied the effect of several doses of tocainide HCl on tinnitus in order to select an appropriate dosage. Nineteen patients with obstructive tinnitus of various aetiologies were admitted to the study. There were 10 women and nine men. Their mean age was 54 years (range 22–67 years). Tocainide was administered in five different doses in a single-blind controlled trial. To be able to judge the effect under steady conditions, each dose was given for four days, as shown in Table I. On the fourth day of each period the patients had to record the degree of impediment caused by the tinitus on a six-point scale (Table II). They were also asked to report all sideeffects.

Type
Session V. Treatment Methods and Results (Chairman: A. Shulman)
Copyright
Copyright © JLO (1984) Limited 1984

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Bárány, R. (1935) Die Beeinflussung des Ohrensausens durch intiavenös injizierte lokalanästhetica. Acta Otolaryngologica (Stockholm), 23: 201203.CrossRefGoogle Scholar
2.Cathcart, J.M. (1982), Assessment of the value of tocaïinide hydrochloride in the treatment of tinnitus. Journal of Laryngology and Otology, 96: 981984.CrossRefGoogle ScholarPubMed
3.Emmett, J. R. and Shea, J. J. (1980) Treatment of tinnitus with tocainide hydrochloride. Journal of Laryngology and Otology, 88: 442446.Google Scholar
4.Israel, J.M., Connelly, J.S., McTigue, S.T., Brummett, R.E. and Brown, J. (1982), Lidocaïine in the treatment of tinnitus aurium. Archives of Otolaryngology, 108: 471473.CrossRefGoogle ScholarPubMed
5.Lewy, R.B. (1937), Treatment of tinnitus aurium by the intravenous use of local anaesthetic agents. Archives Otolaryngology, 25: 178183.Google Scholar
6.Martin, F.W. and Colman, B.H. (1980), Tinnitus: a double-blind cross-over controlled trial to evaluate the use of lignocaïne. Clinical Otolaryngology, 5: 311.Google Scholar
7.Melding, P.S., Goodey, R.J. and Thorne, P.R. (1978), The use of intravenous lignocaïne in the diagnosis and treatment of tinnitus. Journal of Laryngology and Otology, 92: 115121.CrossRefGoogle ScholarPubMed
8.Smith, E.R. (1981), The development of tocaînide. In: Workshop on tocaînide. Ed. Pottage, A. and Ryden, L.. AB Hässle, Möludal, Sweden, pp. 1823.Google Scholar
9.Vernon, J. (1977), Attempts to relieve tinnitus. Journal of the American Audiological Society, 2: 124131.Google Scholar